Mouse Sema4a Knockout Project (CRISPR/Cas9)

Total Page:16

File Type:pdf, Size:1020Kb

Mouse Sema4a Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Sema4a Knockout Project (CRISPR/Cas9) Objective: To create a Sema4a knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Sema4a gene (NCBI Reference Sequence: NM_013658 ; Ensembl: ENSMUSG00000028064 ) is located on Mouse chromosome 3. 15 exons are identified, with the ATG start codon in exon 2 and the TAA stop codon in exon 15 (Transcript: ENSMUST00000029700). Exon 2~10 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Homozygotes for a knock-out allele show no obvious brain defects but exhibit impaired T cell priming and defective Th1 responses. Homozygotes for a gene trap allele show severe retinal degeneration with reduced retinal vessels, depigmentation and dysfunction of both rod and cone photoreceptors. Exon 2 starts from the coding region. Exon 2~10 covers 49.74% of the coding region. The size of effective KO region: ~6856 bp. The KO region does not have any other known gene. Page 1 of 10 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 4 5 6 7 8 9 10 15 Legends Exon of mouse Sema4a Knockout region Page 2 of 10 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 701 bp section upstream of Exon 2 is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section downstream of Exon 10 is aligned with itself to determine if there are tandem repeats. Tandem repeats are found in the dot plot matrix. The gRNA site is selected outside of these tandem repeats. Page 3 of 10 https://www.alphaknockout.com Overview of the GC Content Distribution (up) Window size: 300 bp Sequence 12 Summary: Full Length(701bp) | A(23.97% 168) | C(23.25% 163) | T(18.69% 131) | G(34.09% 239) Note: The 701 bp section upstream of Exon 2 is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution (down) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(22.3% 446) | C(26.55% 531) | T(30.4% 608) | G(20.75% 415) Note: The 2000 bp section downstream of Exon 10 is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 4 of 10 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 701 1 701 701 100.0% chr3 - 88454818 88455518 701 browser details YourSeq 40 56 155 701 95.5% chr11 - 53916566 53940005 23440 browser details YourSeq 31 292 351 701 73.6% chr10 + 9119365 9119416 52 browser details YourSeq 25 60 87 701 96.5% chr11 - 65047254 65047284 31 browser details YourSeq 22 564 587 701 87.0% chr12 - 104793264 104793286 23 browser details YourSeq 22 392 414 701 100.0% chr1 - 128874851 128874874 24 browser details YourSeq 21 541 561 701 100.0% chr10 - 20544605 20544625 21 browser details YourSeq 20 46 65 701 100.0% chr13 - 29840438 29840457 20 browser details YourSeq 20 653 672 701 100.0% chr14 + 16488031 16488050 20 Note: The 701 bp section upstream of Exon 2 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr3 - 88445991 88447990 2000 browser details YourSeq 73 255 582 2000 92.0% chr4 - 155038870 155039336 467 browser details YourSeq 64 263 811 2000 93.3% chr7 + 143227188 143356115 128928 browser details YourSeq 53 291 597 2000 76.2% chr1 + 84924932 84925200 269 browser details YourSeq 52 291 806 2000 63.3% chr1 + 36055899 36056163 265 browser details YourSeq 51 262 343 2000 90.5% chr10 - 69364491 69364770 280 browser details YourSeq 50 242 335 2000 91.7% chr7 - 24496126 24496323 198 browser details YourSeq 49 262 333 2000 91.6% chr11 - 77596717 77596795 79 browser details YourSeq 49 262 335 2000 90.0% chr5 + 79715938 79716016 79 browser details YourSeq 48 262 345 2000 81.7% chr2 - 144474210 144474289 80 browser details YourSeq 48 296 570 2000 92.9% chr16 + 87468723 87469105 383 browser details YourSeq 47 789 886 2000 92.8% chr1 - 153367843 153368251 409 browser details YourSeq 46 262 337 2000 92.6% chr7 - 19927444 19927520 77 browser details YourSeq 46 262 334 2000 92.6% chr14 + 32614938 32615011 74 browser details YourSeq 46 262 334 2000 92.6% chr10 + 63044707 63044780 74 browser details YourSeq 45 268 333 2000 84.9% chr4 - 103165358 103165424 67 browser details YourSeq 45 262 333 2000 92.5% chr1 - 171336552 171336624 73 browser details YourSeq 45 262 334 2000 91.0% chr16 + 20081264 20081337 74 browser details YourSeq 45 262 333 2000 92.5% chr11 + 84717834 84717906 73 browser details YourSeq 44 262 333 2000 89.1% chr11 + 101384482 101384556 75 Note: The 2000 bp section downstream of Exon 10 is BLAT searched against the genome. No significant similarity is found. Page 5 of 10 https://www.alphaknockout.com Gene and protein information: Sema4a sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A [ Mus musculus (house mouse) ] Gene ID: 20351, updated on 10-Oct-2019 Gene summary Official Symbol Sema4a provided by MGI Official Full Name sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) Primary source 4A provided by MGI See related MGI:MGI:107560 Gene type Ensembl:ENSMUSG00000028064 RefSeq status protein coding Organism VALIDATED Lineage Mus musculus Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Also known as Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Expression SemB; Semab; AI132332 Orthologs Broad expression in colon adult (RPKM 43.5), duodenum adult (RPKM 41.8) and 25 other tissues See more human all Genomic context Location: 3; 3 F1 See Sema4a in Genome Data Viewer Exon count: 21 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 3 NC_000069.6 (88435959..88461240, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 3 NC_000069.5 (88239884..88265104, complement) Chromosome 3 - NC_000069.6 Page 6 of 10 https://www.alphaknockout.com Transcript information: This gene has 19 transcripts Gene: Sema4a ENSMUSG00000028064 Description sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A [Source:MGI Symbol;Acc:MGI:107560] Gene Synonyms SemB, Semab Location Chromosome 3: 88,435,959-88,461,182 reverse strand. GRCm38:CM000996.2 About this gene This gene has 19 transcripts (splice variants), 410 orthologues, 19 paralogues, is a member of 1 Ensembl protein family and is associated with 20 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Sema4a- ENSMUST00000029700.11 3205 760aa ENSMUSP00000029700.5 Protein coding CCDS17475 Q62178 TSL:1 201 GENCODE basic APPRIS P1 Sema4a- ENSMUST00000165898.7 3125 760aa ENSMUSP00000128510.1 Protein coding CCDS17475 Q62178 TSL:5 213 GENCODE basic APPRIS P1 Sema4a- ENSMUST00000169222.7 3084 760aa ENSMUSP00000128887.1 Protein coding CCDS17475 Q62178 TSL:5 215 GENCODE basic APPRIS P1 Sema4a- ENSMUST00000166237.7 3046 760aa ENSMUSP00000125909.1 Protein coding CCDS17475 Q62178 TSL:1 214 GENCODE basic APPRIS P1 Sema4a- ENSMUST00000107531.7 2897 628aa ENSMUSP00000103155.1 Protein coding - D3YWV5 TSL:5 202 GENCODE basic Sema4a- ENSMUST00000127436.7 845 233aa ENSMUSP00000118706.1 Protein coding - D3YZ30 CDS 3' 205 incomplete TSL:3 Sema4a- ENSMUST00000147200.7 706 203aa ENSMUSP00000123061.1 Protein coding - D3YUM4 CDS 3' 210 incomplete TSL:5 Sema4a- ENSMUST00000141471.1 630 60aa ENSMUSP00000114330.1 Protein coding - D3YVM6 CDS 3' 208 incomplete TSL:5 Sema4a- ENSMUST00000125526.7 506 113aa ENSMUSP00000119028.1 Protein coding - D3Z336 CDS 3' 204 incomplete TSL:3 Sema4a- ENSMUST00000123753.7 385 17aa ENSMUSP00000120084.1 Protein coding - D3YWK5 CDS 3' 203 incomplete TSL:2 Sema4a- ENSMUST00000184487.7 866 170aa ENSMUSP00000139126.1 Nonsense mediated - V9GXF5 TSL:5 216 decay Sema4a- ENSMUST00000184876.7 748 180aa ENSMUSP00000139159.1 Nonsense mediated - V9GXH9 TSL:5 217 decay Sema4a- ENSMUST00000185137.7 699 47aa ENSMUSP00000138858.1 Nonsense mediated - V9GWW2 CDS 5' 219 decay incomplete TSL:3 Sema4a- ENSMUST00000135539.7 2487 No - Retained intron - - TSL:2 206 protein Sema4a- ENSMUST00000149145.1 2357 No - Retained intron - - TSL:5 Page 7 of 10 https://www.alphaknockout.com 211 protein Sema4a- ENSMUST00000156108.7 2108 No - Retained intron - - TSL:2 212 protein Sema4a- ENSMUST00000135732.7 713 No - Retained intron - - TSL:3 207 protein Sema4a- ENSMUST00000184972.1 465 No - Retained intron - - TSL:2 218 protein Sema4a- ENSMUST00000146921.1 371 No - lncRNA - - TSL:3 209 protein Page 8 of 10 https://www.alphaknockout.com
Recommended publications
  • Molecular Effects of Isoflavone Supplementation Human Intervention Studies and Quantitative Models for Risk Assessment
    Molecular effects of isoflavone supplementation Human intervention studies and quantitative models for risk assessment Vera van der Velpen Thesis committee Promotors Prof. Dr Pieter van ‘t Veer Professor of Nutritional Epidemiology Wageningen University Prof. Dr Evert G. Schouten Emeritus Professor of Epidemiology and Prevention Wageningen University Co-promotors Dr Anouk Geelen Assistant professor, Division of Human Nutrition Wageningen University Dr Lydia A. Afman Assistant professor, Division of Human Nutrition Wageningen University Other members Prof. Dr Jaap Keijer, Wageningen University Dr Hubert P.J.M. Noteborn, Netherlands Food en Consumer Product Safety Authority Prof. Dr Yvonne T. van der Schouw, UMC Utrecht Dr Wendy L. Hall, King’s College London This research was conducted under the auspices of the Graduate School VLAG (Advanced studies in Food Technology, Agrobiotechnology, Nutrition and Health Sciences). Molecular effects of isoflavone supplementation Human intervention studies and quantitative models for risk assessment Vera van der Velpen Thesis submitted in fulfilment of the requirements for the degree of doctor at Wageningen University by the authority of the Rector Magnificus Prof. Dr M.J. Kropff, in the presence of the Thesis Committee appointed by the Academic Board to be defended in public on Friday 20 June 2014 at 13.30 p.m. in the Aula. Vera van der Velpen Molecular effects of isoflavone supplementation: Human intervention studies and quantitative models for risk assessment 154 pages PhD thesis, Wageningen University, Wageningen, NL (2014) With references, with summaries in Dutch and English ISBN: 978-94-6173-952-0 ABSTRact Background: Risk assessment can potentially be improved by closely linked experiments in the disciplines of epidemiology and toxicology.
    [Show full text]
  • The Complete Genome of an Endogenous Nimavirus (Nimav-1 Lva) from the Pacific Whiteleg Shrimp Penaeus (Litopenaeus) Vannamei
    G C A T T A C G G C A T genes Article The Complete Genome of an Endogenous Nimavirus (Nimav-1_LVa) From the Pacific Whiteleg Shrimp Penaeus (Litopenaeus) Vannamei Weidong Bao 1,* , Kathy F. J. Tang 2 and Acacia Alcivar-Warren 3,4,* 1 Genetic Information Research Institute, 20380 Town Center Lane, Suite 240, Cupertino, CA 95014, USA 2 Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, 106 Nanjing Road, Qingdao 266071, China; [email protected] 3 Fundación para la Conservation de la Biodiversidad Acuática y Terrestre (FUCOBI), Quito EC1701, Ecuador 4 Environmental Genomics Inc., ONE HEALTH Epigenomics Educational Initiative, P.O. Box 196, Southborough, MA 01772, USA * Correspondence: [email protected] (W.B.); [email protected] (A.A.-W.) Received: 17 December 2019; Accepted: 9 January 2020; Published: 14 January 2020 Abstract: White spot syndrome virus (WSSV), the lone virus of the genus Whispovirus under the family Nimaviridae, is one of the most devastating viruses affecting the shrimp farming industry. Knowledge about this virus, in particular, its evolution history, has been limited, partly due to its large genome and the lack of other closely related free-living viruses for comparative studies. In this study, we reconstructed a full-length endogenous nimavirus consensus genome, Nimav-1_LVa (279,905 bp), in the genome sequence of Penaeus (Litopenaeus) vannamei breed Kehai No. 1 (ASM378908v1). This endogenous virus seemed to insert exclusively into the telomeric pentanucleotide microsatellite (TAACC/GGTTA)n. It encoded 117 putative genes, with some containing introns, such as g012 (inhibitor of apoptosis, IAP), g046 (crustacean hyperglycemic hormone, CHH), g155 (innexin), g158 (Bax inhibitor 1 like).
    [Show full text]
  • SEMA4A (NM 022367) Human Tagged ORF Clone Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC202231L4 SEMA4A (NM_022367) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: SEMA4A (NM_022367) Human Tagged ORF Clone Tag: mGFP Symbol: SEMA4A Synonyms: CORD10; RP35; SEMAB; SEMB Vector: pLenti-C-mGFP-P2A-Puro (PS100093) E. coli Selection: Chloramphenicol (34 ug/mL) Cell Selection: Puromycin ORF Nucleotide The ORF insert of this clone is exactly the same as(RC202231). Sequence: Restriction Sites: SgfI-MluI Cloning Scheme: ACCN: NM_022367 ORF Size: 2283 bp This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 3 SEMA4A (NM_022367) Human Tagged ORF Clone – RC202231L4 OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_022367.2, NP_071762.2 RefSeq Size: 3313 bp RefSeq ORF: 2286 bp Locus ID: 64218 UniProt ID: Q9H3S1 Domains: Sema, PSI, PSI Protein Families: Transmembrane Protein Pathways: Axon guidance MW: 83.6 kDa Gene Summary: This gene encodes a member of the semaphorin family of soluble and transmembrane proteins.
    [Show full text]
  • Entrez ID Gene Name Fold Change Q-Value Description
    Entrez ID gene name fold change q-value description 4283 CXCL9 -7.25 5.28E-05 chemokine (C-X-C motif) ligand 9 3627 CXCL10 -6.88 6.58E-05 chemokine (C-X-C motif) ligand 10 6373 CXCL11 -5.65 3.69E-04 chemokine (C-X-C motif) ligand 11 405753 DUOXA2 -3.97 3.05E-06 dual oxidase maturation factor 2 4843 NOS2 -3.62 5.43E-03 nitric oxide synthase 2, inducible 50506 DUOX2 -3.24 5.01E-06 dual oxidase 2 6355 CCL8 -3.07 3.67E-03 chemokine (C-C motif) ligand 8 10964 IFI44L -3.06 4.43E-04 interferon-induced protein 44-like 115362 GBP5 -2.94 6.83E-04 guanylate binding protein 5 3620 IDO1 -2.91 5.65E-06 indoleamine 2,3-dioxygenase 1 8519 IFITM1 -2.67 5.65E-06 interferon induced transmembrane protein 1 3433 IFIT2 -2.61 2.28E-03 interferon-induced protein with tetratricopeptide repeats 2 54898 ELOVL2 -2.61 4.38E-07 ELOVL fatty acid elongase 2 2892 GRIA3 -2.60 3.06E-05 glutamate receptor, ionotropic, AMPA 3 6376 CX3CL1 -2.57 4.43E-04 chemokine (C-X3-C motif) ligand 1 7098 TLR3 -2.55 5.76E-06 toll-like receptor 3 79689 STEAP4 -2.50 8.35E-05 STEAP family member 4 3434 IFIT1 -2.48 2.64E-03 interferon-induced protein with tetratricopeptide repeats 1 4321 MMP12 -2.45 2.30E-04 matrix metallopeptidase 12 (macrophage elastase) 10826 FAXDC2 -2.42 5.01E-06 fatty acid hydroxylase domain containing 2 8626 TP63 -2.41 2.02E-05 tumor protein p63 64577 ALDH8A1 -2.41 6.05E-06 aldehyde dehydrogenase 8 family, member A1 8740 TNFSF14 -2.40 6.35E-05 tumor necrosis factor (ligand) superfamily, member 14 10417 SPON2 -2.39 2.46E-06 spondin 2, extracellular matrix protein 3437
    [Show full text]
  • Panel-Based Next Generation Sequencing As a Reliable and Efficient Technique to Detect Mutations in Unselected Patients With
    European Journal of Human Genetics (2014) 22, 99–104 & 2014 Macmillan Publishers Limited All rights reserved 1018-4813/14 www.nature.com/ejhg ARTICLE Panel-based next generation sequencing as a reliable and efficient technique to detect mutations in unselected patients with retinal dystrophies Nicola Glo¨ckle1,9, Susanne Kohl2,9, Julia Mohr1, Tim Scheurenbrand1, Andrea Sprecher1, Nicole Weisschuh2, Antje Bernd3,Gu¨nther Rudolph4, Max Schubach1, Charlotte Poloschek5, Eberhart Zrenner3, Saskia Biskup1, Wolfgang Berger6,7,8, Bernd Wissinger2,10 and John Neidhardt*,6,10 Hereditary retinal dystrophies (RD) constitute a group of blinding diseases that are characterized by clinical variability and pronounced genetic heterogeneity. The different forms of RD can be caused by mutations in 4100 genes, including 41600 exons. Consequently, next generation sequencing (NGS) technologies are among the most promising approaches to identify mutations in RD. So far, NGS is not routinely used in gene diagnostics. We developed a diagnostic NGS pipeline to identify mutations in 170 genetically and clinically unselected RD patients. NGS was applied to 105 RD-associated genes. Underrepresented regions were examined by Sanger sequencing. The NGS approach was successfully established using cases with known sequence alterations. Depending on the initial clinical diagnosis, we identified likely causative mutations in 55% of retinitis pigmentosa and 80% of Bardet–Biedl or Usher syndrome cases. Seventy-one novel mutations in 40 genes were newly associated with RD. The genes USH2A, EYS, ABCA4, and RHO were more frequently affected than others. Occasionally, cases carried mutations in more than one RD-associated gene. In addition, we found possible dominant de-novo mutations in cases with sporadic RD, which implies consequences for counseling of patients and families.
    [Show full text]
  • Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
    Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacrifices. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ......................................................
    [Show full text]
  • Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss
    cells Review Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss 1, 1, 1 1,2,3 1 Gayle B. Collin y, Navdeep Gogna y, Bo Chang , Nattaya Damkham , Jai Pinkney , Lillian F. Hyde 1, Lisa Stone 1 , Jürgen K. Naggert 1 , Patsy M. Nishina 1,* and Mark P. Krebs 1,* 1 The Jackson Laboratory, Bar Harbor, Maine, ME 04609, USA; [email protected] (G.B.C.); [email protected] (N.G.); [email protected] (B.C.); [email protected] (N.D.); [email protected] (J.P.); [email protected] (L.F.H.); [email protected] (L.S.); [email protected] (J.K.N.) 2 Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand 3 Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand * Correspondence: [email protected] (P.M.N.); [email protected] (M.P.K.); Tel.: +1-207-2886-383 (P.M.N.); +1-207-2886-000 (M.P.K.) These authors contributed equally to this work. y Received: 29 February 2020; Accepted: 7 April 2020; Published: 10 April 2020 Abstract: Inherited retinal degeneration (RD) leads to the impairment or loss of vision in millions of individuals worldwide, most frequently due to the loss of photoreceptor (PR) cells. Animal models, particularly the laboratory mouse, have been used to understand the pathogenic mechanisms that underlie PR cell loss and to explore therapies that may prevent, delay, or reverse RD. Here, we reviewed entries in the Mouse Genome Informatics and PubMed databases to compile a comprehensive list of monogenic mouse models in which PR cell loss is demonstrated.
    [Show full text]
  • Peripheral Nerve Single-Cell Analysis Identifies Mesenchymal Ligands That Promote Axonal Growth
    Research Article: New Research Development Peripheral Nerve Single-Cell Analysis Identifies Mesenchymal Ligands that Promote Axonal Growth Jeremy S. Toma,1 Konstantina Karamboulas,1,ª Matthew J. Carr,1,2,ª Adelaida Kolaj,1,3 Scott A. Yuzwa,1 Neemat Mahmud,1,3 Mekayla A. Storer,1 David R. Kaplan,1,2,4 and Freda D. Miller1,2,3,4 https://doi.org/10.1523/ENEURO.0066-20.2020 1Program in Neurosciences and Mental Health, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada, 2Institute of Medical Sciences University of Toronto, Toronto, Ontario M5G 1A8, Canada, 3Department of Physiology, University of Toronto, Toronto, Ontario M5G 1A8, Canada, and 4Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5G 1A8, Canada Abstract Peripheral nerves provide a supportive growth environment for developing and regenerating axons and are es- sential for maintenance and repair of many non-neural tissues. This capacity has largely been ascribed to paracrine factors secreted by nerve-resident Schwann cells. Here, we used single-cell transcriptional profiling to identify ligands made by different injured rodent nerve cell types and have combined this with cell-surface mass spectrometry to computationally model potential paracrine interactions with peripheral neurons. These analyses show that peripheral nerves make many ligands predicted to act on peripheral and CNS neurons, in- cluding known and previously uncharacterized ligands. While Schwann cells are an important ligand source within injured nerves, more than half of the predicted ligands are made by nerve-resident mesenchymal cells, including the endoneurial cells most closely associated with peripheral axons. At least three of these mesen- chymal ligands, ANGPT1, CCL11, and VEGFC, promote growth when locally applied on sympathetic axons.
    [Show full text]
  • Heme Oxygenase-1 Orchestrates the Immunosuppressive Program of Tumor-Associated Macrophages
    Heme oxygenase-1 orchestrates the immunosuppressive program of tumor-associated macrophages Emmanuelle Alaluf, … , Alain Le Moine, Stanislas Goriely JCI Insight. 2020. https://doi.org/10.1172/jci.insight.133929. Research In-Press Preview Immunology Oncology Tumor-Associated Macrophages (TAMs) contribute to the maintenance of a strong immunosuppressive environment, supporting tumor progression and resistance to treatment. To date, the mechanisms that drive acquisition of these immunosuppressive features are still poorly defined. Heme oxygenase-1 (HO-1) is the rate-limiting enzyme that catabolizes free heme. It displays important cytoprotective, anti-inflammatory and antioxidant properties. A growing body of evidence suggests that HO-1 may also promote tumor development. Herein, we show that HO-1 is highly expressed in monocytic cells in the tumor microenvironment (TME) once they differentiate into TAMs. Deletion of HO-1 in the myeloid compartment enhances the beneficial effects of a therapeutic antitumor vaccine by restoring CD8 T-cell proliferation and cytotoxicity. We further show that induction of HO-1 plays a major role on monocyte education by tumor cells by modulating their transcriptional and epigenetic programs. These results identify HO-1 as a valuable therapeutic target to reprogram the TME and synergize with current cancer therapies to facilitate antitumoral response. Find the latest version: https://jci.me/133929/pdf Heme oxygenase-1 orchestrates the immunosuppressive program of tumor-associated macrophages Emmanuelle Alaluf1,
    [Show full text]
  • How Can an Interactive Visual Analytics Tool Help Biomedical Scientists Investigate Genotype-Phenotype Relationships?
    How Can An Interactive Visual Analytics Tool Help Biomedical Scientists Investigate Genotype-Phenotype Relationships? By Erik Jon Segerdell A Thesis Presented to the Department of Medical Informatics and Clinical Epidemiology and the Oregon Health & Science University School of Medicine in partial fulfillment of the requirements for the degree of Master of Science November 2015 Department of Medical Informatics and Clinical Epidemiology School of Medicine Oregon Health & Science University Certificate of Approval This is to certify that the Master's thesis of Erik Segerdell has been approved Beth Wilmot, Ph.D., Mentor Melissa Haendel, Ph.D. Harry Hochheiser, Ph.D. Michelle Hribar, Ph.D. Contents Acknowledgments vi Abstract vii 1 Introduction 1 1.1 The animal model data landscape . .1 1.2 Biomedical data visualization . .2 1.2.1 Graph-structured data . .2 1.2.2 The state of current tools . .4 1.3 The study . .6 1.3.1 Purpose and philosophy . .6 1.3.2 Discount usability and user-centered design . .7 2 Methods 10 2.1 Overview . 10 2.2 Design and evaluation strategy . 11 2.2.1 Iterative design . 11 2.2.2 Users and user sessions . 12 2.3 Mockups, prototype, and user tasks . 14 2.3.1 First iteration . 14 2.3.2 Second iteration . 17 2.4 Biological use cases . 21 2.5 Data sources . 22 i 2.6 Software . 23 2.7 Evaluation methods . 23 3 Results 26 3.1 Overview . 26 3.2 The mockups . 27 3.2.1 Scenario development and interface features . 27 3.2.2 User feedback and requests .
    [Show full text]
  • Could Ion Channels-Encoding Or Related Genes Act As Modifier Of
    International Journal of Molecular Sciences Article New Omics—Derived Perspectives on Retinal Dystrophies: Could Ion Channels-Encoding or Related Genes Act as Modifier of Pathological Phenotype? Luigi Donato 1,2 , Concetta Scimone 1,2,* , Simona Alibrandi 1,3, Ebtesam Mohamed Abdalla 4, Karim Mahmoud Nabil 5, Rosalia D’Angelo 1 and Antonina Sidoti 1 1 Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Division of Medical Biotechnologies and Preventive Medicine, University of Messina, 98125 Messina, Italy; [email protected] (L.D.); [email protected] (S.A.); [email protected] (R.D.); [email protected] (A.S.) 2 Department of Biomolecular Strategies, Genetics and Avant-Garde Therapies, I.E.ME.S.T., 90139 Palermo, Italy 3 Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98125 Messina, Italy 4 Department of Human Genetics, Medical Research Institute, University of Alexandria, Alexandria 21500, Egypt; [email protected] 5 Department of Ophthalmology, Faculty of Medicine, University of Alexandria, Alexandria 21500, Egypt; [email protected] * Correspondence: [email protected]; Tel.: +39-090-221-3136 Abstract: Ion channels are membrane-spanning integral proteins expressed in multiple organs, including the eye. Here, ion channels play a role in several physiological processes, like signal trans- mission and visual processing. A wide range of mutations have been reported in the corresponding genes and their interacting subunit coding genes, which contribute significantly to a wide spectrum of ocular diseases collectively called channelopathies, a subgroup of inherited retinal dystrophies. Such mutations result in either a loss or gain-of channel functions affecting the structure, assem- Citation: Donato, L.; Scimone, C.; bly, trafficking and localization of channel proteins.
    [Show full text]
  • WRN Germline Mutation Is the Likely Inherited Etiology of Various Cancer Types in One Iranian Family
    ORIGINAL RESEARCH published: 07 June 2021 doi: 10.3389/fonc.2021.648649 WRN Germline Mutation Is the Likely Inherited Etiology of Various Cancer Types in One Iranian Family Mahnaz Norouzi 1, Mohammad Shafiei 1*†,ZeinabAbdollahi2,PanizMiar2, Hamid Galehdari 1, Mohammad Hasan Emami 3, Mehrdad Zeinalian 2 and Mohammad Amin Tabatabaiefar 2,4*† Edited by: 1 Department of Biology, Faculty of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran, 2 Department of Genetics Israel Gomy, and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran, 3 Department of Dana–Farber Cancer Institute, Gastroenterology, Poursina Hakim Digestive Disease Research Center, Isfahan University of Medical Sciences, Isfahan, Iran, United States 4 Pediatric Inherited Diseases Research Center, Research Institute for Primordial Prevention of Noncommunicable Disease, Reviewed by: Isfahan University of Medical Sciences, Isfahan, Iran Mev Dominguez-Valentin, Oslo University Hospital, Norway Background: Familial cancers comprise a considerable distribution of colorectal cancers Reza Ghasemi, Washington University School of (CRCs), of which only about 5% occurs through well-established hereditary syndromes. It Medicine in St. Louis, has been demonstrated that deleterious variants at the newly identified cancer- United States predisposing genes could describe the etiology of undefined familial cancers. *Correspondence: Mohammad Amin Tabatabaiefar Methods: The present study aimed to identify the genetic etiology in a 32-year-old man [email protected]; with early onset familial CRC employing several molecular diagnostic techniques. DNA [email protected] Mohammad Shafiei was extracted from tumoral and normal formalin-fixed-paraffin-embedded (FFPE) shafi[email protected] blocks, and microsatellite instability (MSI) was evaluated. Immunohistochemistry † staining of MMR proteins was performed on tumoral FFPE blocks.
    [Show full text]